Vensun Pharmaceuticals
Yardley
About Vensun Pharmaceuticals
Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms. As a rapidly emerging generic pharmaceutical company, Vensun has filed several Abbreviated New Drug Applications (ANDAs) with the FDA through its partnerships and currently has over 30 products in active development. We are actively seeking additional opportunities for partnerships, strategic alliances, and product acquisitions to enhance our existing development portfolio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $49.7M
- Funding stage: M&A
- Last round: Series C (Dec 2016)
- Website: vensunrx.com
- Phone: 215-543-3737
Industries & Categories
Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vensun-pharmaceuticals-99956 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.